C3 and Thrombocytopenia: B2-CIC presence in patients with thrombotic antecedents was significantly associated with a decrease of the platelet count and complement factors C3 and C4 levels as well as with a higher incidence of thrombocytopenia, thus confirming what has been observed in previous single-center studies (26–28).